(Q37812516)

23 August 2017

Oesophagogastric junction adenocarcinoma: which therapeutic approach? (English)

1 reference

23 August 2017

1 reference

Christophe Mariette

1

1 reference

23 August 2017

Guillaume Piessen

2

1 reference

23 August 2017

Nicolas Briez

3

1 reference

23 August 2017

Caroline Gronnier

4

1 reference

23 August 2017

Jean Pierre Triboulet

5

1 reference

23 August 2017

23 November 2010

1 reference

Lancet Oncology Commission

23 August 2017

1 reference

23 August 2017

12

1 reference

23 August 2017

296-305

1 reference

23 August 2017

3

1 reference

Demographic variations in the rising incidence of esophageal adenocarcinoma in white males

23 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Surgical management of and long-term survival after adenocarcinoma of the cardia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Application of the new classification for cancer of the cardia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Endoscopic resection of early oesophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Radiofrequency ablation in Barrett's esophagus with dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Endoscopic resection of early oesophageal and gastric neoplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Early Barrett's carcinoma with "low-risk" submucosal invasion: long-term results of endoscopic resection with a curative intent

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Early gastric cancer: lymph node metastasis starts with deep mucosal infiltration

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

pTNM and residual tumor classifications: problems of assessment and prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

The role of surgery in the management of oesophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Extended local resection for advanced gastric cancer: increased survival versus increased morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Systematic review of minimally invasive resection for gastro-oesophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Future strategies and adjuvant treatment of gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial. The Dutch Gastric Cancer Group (DGCG).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

A comparison of multimodal therapy and surgery for esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Postoperative chemoradiotherapy for gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970125-X

7 January 2021

10.1016/S1470-2045(10)70125-X

Identifiers

DOI

1 reference

23 August 2017

1 reference